Vaccine strategies to enhance immune responses in the aged. - Wikidata - wikimedia - TriplyDB

Vaccine strategies to enhance immune responses in the aged.

Vaccine strategies to enhance immune responses in the aged.

http://www.wikidata.org/entity/Q37179398

about

Innate immune responses in the ageing lung.Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older.Loss of Phagocytic and Antigen Cross-Presenting Capacity in Aging Dendritic Cells Is Associated with Mitochondrial Dysfunction.HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine.Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination.Effectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugs.KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection.Influenza immunization in hemodialyzed or kidney transplanted adolescents and young adults.Interventions to restore appropriate immune function in the elderly.Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.

P2860

Q30242022-C2DEC7E5-D2EE-4A72-BC56-374FE76E8346 Q34067461-BDA1BB20-EB62-4AC3-ABCC-7472EFD9ED9F Q36031500-068BB402-9D96-42AA-AD19-FC8E8E77CCF6 Q36812854-9F1830F7-E9D7-4E57-9DFC-CF7F24CB4794 Q37385591-068369CB-916C-47D7-B0E4-86B5A9108F87 Q40571341-A242A1F7-71DF-4BBC-9607-7BEBD31A679E Q41877181-4694BA25-7682-447E-BB35-B112252384EA Q42209552-9CF05F12-4C11-4F2B-8403-D70A18CB3C55 Q49186484-345AC8AD-F28F-41B2-BC82-4E7F1F36C509 Q51743232-C332B020-AA78-45E5-B2BB-DC5FDA4567FE

P2860

Vaccine strategies to enhance immune responses in the aged.

http://www.wikidata.org/entity/Q37179398

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vaccine strategies to enhance immune responses in the aged.

@en

Vaccine strategies to enhance immune responses in the aged.

@nl

type

label

Vaccine strategies to enhance immune responses in the aged.

@en

Vaccine strategies to enhance immune responses in the aged.

@nl

prefLabel

Vaccine strategies to enhance immune responses in the aged.

@en

Vaccine strategies to enhance immune responses in the aged.

@nl

P1433

Q37179398-6564EF0E-932B-4122-8A23-2D4950B75B7D

P1476

Q37179398-9F0FE75B-2271-410A-80F4-92CCC959B648

P2093

Q37179398-70E1C7BB-2865-435F-BDE6-883111F69181

Q37179398-EACB810D-848B-462E-8268-57AB5718A042

P2860

Q37179398-060C5C04-2C2D-4B53-B242-C3602574CD1A

Q37179398-10C58839-114B-4AFA-ADF0-97336015AF3D

Q37179398-19AE52EE-3F0E-4D1E-B6EC-D36CFE3370C3

Q37179398-1B3F3B70-498E-41A5-A3C6-B79F0A360A04

Q37179398-1DBE8173-34E4-4F02-ACB1-74319C30B8C4

Q37179398-1E6E6302-916B-4C31-BE57-963E503FF6CC

Q37179398-20D4397D-CE5E-4894-A6B4-647B1142DF08

Q37179398-28328B69-B546-4B8C-BD69-16CE893D33E5

Q37179398-33E1386D-FE17-484D-933F-57270F7290A5

Q37179398-3ACCFC28-11C6-47BC-977C-45FC60E7479C

P304

Q37179398-99773409-8D0F-4A77-AEE6-A5362E93C3DA

P31

Q37179398-461980A4-C5E5-4B1E-A4C7-682057A5E99B

P356

Q37179398-D6F63A78-DD6F-42F3-82EB-A16FC438EF8B

P433

Q37179398-A35C1EB9-1581-4D8A-A715-4EA3886FBA74

P478

Q37179398-3AFC1B96-95FB-4367-A5A0-125D8C2504F9

P577

Q37179398-8F221A7B-3C67-4CD7-9A7A-44403265CB88

P698

Q37179398-63F31199-2A92-4198-A1A2-2A62B742EEEC

P932

Q37179398-6ABFFE99-A171-405E-A310-8F26E146A7A5

P356

J.COI.2013.05.014

P1433

Current Opinion in Immunology

P1476

Vaccine strategies to enhance immune responses in the aged.

@en

P2093

Julie S Lefebvre

http://www.w3.org/2001/XMLSchema#string

Laura Haynes

http://www.w3.org/2001/XMLSchema#string

P2860

Contribution of Toll-like receptor signaling to germinal center antibody responses

Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.

Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

A novel influenza A (H1N1) vaccine in various age groups.

Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine.

Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine.

Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.

High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season.

A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.

Aging of the CD4 T Cell Compartment.

P304

523-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.COI.2013.05.014

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23764092

http://www.w3.org/2001/XMLSchema#string

P932

3775954

http://www.w3.org/2001/XMLSchema#string